1-11 of 11
Lin Gui
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MYD88 L265P Mutation and Other Variants Show Different Molecular Characteristics in Diffuse Large B-Cell Lymphoma Treated with R-CHOP in China

Yan Qin, Tian Qiu, Zucheng Xie, Peng Liu, Jianliang Yang, Xiaohui He, Lin Gui, Shengyu Zhou, Hongxin Jiang, Changgong Zhang, Sheng Yang, Le Tang, Yuankai Shi
Journal: Blood
Blood (2022) 140 (Supplement 1): 9512–9513.
https://doi.org/10.1182/blood-2022-162907
Published: 2022
Journal Articles

Expression Signature and Prognostic Value of BCL2 Translocation for Diffuse Large B-Cell Lymphoma Patients in China

Yan Qin, Tian Qiu, Xinrui Chen, Peng Liu, Jianliang Yang, Xiaohui He, Lin Gui, Shengyu Zhou, Hongxin Jiang, Changgong Zhang, Sheng Yang, Le Tang, Yuankai Shi
Journal: Blood
Blood (2022) 140 (Supplement 1): 12094–12095.
https://doi.org/10.1182/blood-2022-162307
Published: 2022
Journal Articles

Efficacy and Safety of PD-1 Inhibitor Plus Rituximab in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Yan Qin, Xiaohui He, Sheng Yang, Peng Liu, Shengyu Zhou, Jianliang Yang, Lin Gui, Qiaofeng Zhong, Fengyi Zhao, Yuankai Shi, Hongmei Jing, Shiyue Zhang, Ruihan Guo, Yuankai Shi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2485.
https://doi.org/10.1182/blood-2021-152094
Published: 2021
Journal Articles

Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naïve Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study

Yuankai Shi, QingYuan Zhang, Xiaonan Hong, Zhen Wang, Yuhuan Gao, Liqun Zou, Hong Cen, Lin Gui, Yufu Li, Jifeng Feng, Zhao Wang, Mingzhi Zhang, Chuan Jin, Weihua Zhang, Jianda Hu, Chengyun Zheng, Zhendong Zheng, Liling Zhang, Shaoshui Chen, Yunhong Huang, Yun Tang, Yajie Gao, Miaowang Hao, Xiaoling Li, Chunkang Chang, Haiyan Yang, Hui Wu, Lida Shen, Xiaoyan Ke, Liangming Zhang, Yaming Xi, Linhua Yang, Liangzhi Xie
Journal: Blood
Blood (2021) 138 (Supplement 1): 2480.
https://doi.org/10.1182/blood-2021-149861
Published: 2021
Journal Articles

The Significance of Inflammatory Markers in the Prognosis of Newly Diagnosed Multiple Myeloma Patients

Lin Gui, MD, Fei Wang, MDPhD, Jinning Shi, Baoan Chen, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15.
https://doi.org/10.1182/blood-2020-136326
Published: 2020
Journal Articles

Influencing Factors of Non-Genetic Factors Influencing the Overall Survival of Multiple Myeloma Patients

Lin Gui, MD, Fei Wang, MDPhD, Jinning Shi, Baoan Chen, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15.
https://doi.org/10.1182/blood-2020-136863
Published: 2020
Journal Articles

A Phase 1b/2 Study of Chidamide Combined with CHOP in Previously Untreated Patients with Peripheral T-Cell Lymphoma (PTCL)

Yuankai Shi, MD, Lin Gui, MD, Junning Cao, MD, Huilai Zhang, MD, Jun Zhu, MD PhD, Dongmei Ji, MD PhD, Qian Fan, MD, Yuqin Song, MD PhD, Weina Shen, MM, Guiying Bai, MM, Ming-Zhe Han, MD, Shiyu Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2840.
https://doi.org/10.1182/blood-2019-128078
Published: 2019
Journal Articles

A Prognostic Nomogram and Survival Analysis in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients

Shiyu Jiang, Yan Qin, Peng Liu, Jiangliang Yang, Sheng Yang, Xiaohui He, Shengyu Zhou, Lin Gui, Changgong Zhang, Liqiang Zhou, Ming-Zhe Han, Yan Sun, Yuankai Shi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2994.
https://doi.org/10.1182/blood-2018-99-116442
Published: 2018
Journal Articles

Clinical Features and Prognosis of CD20-Positive Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) in Chinese Patients: A Retrospective Single Institution Analysis

Shaoxuan Hu, Xiaohui He, MD, Yuankai Shi, MD PhD, Sheng Yang, MD, Yan Qin, MD, Jianliang Yang, MD, Mei Dong, MD, Shengyu Zhou, MD, Peng Liu, MD, Lin Gui, MD, Changgong Zhang, MD, Liqiang Zhou, MD
Journal: Blood
Blood (2015) 126 (23): 5045.
https://doi.org/10.1182/blood.V126.23.5045.5045
Published: 2015
Journal Articles

Treatment Outcome and Prognostic Model for Stage IE/IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Retrospective Study in a Cohort of 305 Patients with Long Term Follow-up

Yuankai Shi, MD PhD, Bo Jia, Xiaohui He, MD, Youwu Shi, Mei Dong, MD, Jianliang Yang, MD, Liqiang Zhou, MD, Shengyu Zhou, MD, Peng Liu, MD, Yan Qin, MD, Sheng Yang, MD, Hua Lin, MD, Lin Gui, MD, Changgong Zhang, MD, Lin Wang, MD, Shanshan Chen, MD, Puyuan Xing, MD, Hongnan Mo, MD, Mingzhe Han, MD
Journal: Blood
Blood (2015) 126 (23): 2718.
https://doi.org/10.1182/blood.V126.23.2718.2718
Published: 2015
Journal Articles

Efficacy and Safety of Gemcitabine-Based Combination Regimens in Patients with Extranodal Natural Killer/T Cell Lymphoma, Nasal Type

Jingjing Wang, Mei Dong, MD, Xiaohui He, MD, Weihu Wang, MD, Peng Liu, MD, Jianliang Yang, MD, Yan Qin, MD, Lin Gui, MD, Sheng Yang, MD, Yexiong Li, MD PhD, Yuankai Shi, MD PhD, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 3071.
https://doi.org/10.1182/blood.V124.21.3071.3071
Published: 2014